Smnuary Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) is currently based on phenotypical analysis of an expanded pedigree. Diagnostic guidelines ('Amsterdam criteria') proposed by the International Collaborative Group on HNPCC are often too stringent for use with small families. There is also the possibility of false-positive diagnosis in large pedigrees that may contain chance clusters of tumours. This study was conducted to determine the effect of family size on the probability of diagnosing HNPCC according to the Amsterdam criteria. A total of 1052 patients with colorectal cancer were classified as HNPCC or non-HNPCC according to the Amsterdam criteria. Associations between this diagnosis and the size of the first-degree pedigree were evaluated in logistic regression and linear discriminant analyses. Logistic regression showed a significant association for family size with the Amsterdam-criteria-based HNPCC diagnosis. Linear discriminant analysis showed that HNPCC diagnosis was most likely to occur when first-degree pedigrees contained more than seven relatives. Failure to consider family size in phenotypic diagnosis of HNPCC can lead to both under-and overestimation of the frequency of this disease. Small pedigrees must be (Fishel et al., 1993; Bronner et al., 1994; Nicolaides et al., 1994; Papadopoulos et al., 1994), phenotypical pedigree analysis remains the primary approach to identifying this syndrome. Using this approdch, various groups have attempted to estimate the frequency of Lynch syndrome and their results indicate that HNPCC accounts for 0.5-6% of all cases of colorectal cancer (Mecklin, 1987; Vasen et al., 1989; Kee and Collins, 1991; Stephenson et al., 1991; Aaltonen et al., 1994) . The disparity of these results can be attributed in part to the subtle differences in classification criteria used in these studies, and the need for uniformity (particularly in multicentre studies) led to the establishment, in 1990, of the so-called ' al., 1991b). In addition, the probability of finding three cases of colon cancer within the small families that are typical of most Western countnres is fairly limited, and pedigree expansion to second-and third-degree relatives is almost always necessary. However, because of the high incidence of colon tumours, evaluation and verification of expanded pedigree data for all colon cancer patients can represent an enormous amount of work. This approach also requires collaboration by the proband and his/her family and knowledge of distant relatives, which may not be available, particularly in countries in which family ties have become attenuated. On the other hand, when large pedigrees are evaluated there is always a risk of false-positive diagnosis based on chance aggregation of tumours or the effects of common environmental risk factors, such as diet (Khoury et al., 1988).
primaries (synchronous and/or metachronous) . The frequency of endometnril, gastnrc, ovarian and unnary tract tumours is also increased in the vast majority of HNPCC families (Lynch II syndrome or cancer family syndrome) (Lynch et al., 1988; Watson and Lynch, 1993) . Although important advances have recently been made towards the development of a genetic marker for HNPCC (Fishel et al., 1993; Bronner et al., 1994; Nicolaides et al., 1994; Papadopoulos et al., 1994) , phenotypical pedigree analysis remains the primary approach to identifying this syndrome.
Using this approdch, various groups have attempted to estimate the frequency of Lynch syndrome and their results indicate that HNPCC accounts for 0.5-6% of all cases of colorectal cancer (Mecklin, 1987; Vasen et al., 1989 ; Kee and Collins, 1991; Stephenson et al., 1991; Aaltonen et al., 1994) . The disparity of these results can be attributed in part to the subtle differences in classification criteria used in these studies, and the need for uniformity (particularly in multicentre studies) led to the establishment, in 1990, of the so-called 'Amsterdam criteria' by the International Collaborative Group on HNPCC (ICG-HNPCC) (Vasen et al., 1991a al., 1991b) . In addition, the probability of finding three cases of colon cancer within the small families that are typical of most Western countnres is fairly limited, and pedigree expansion to second-and third-degree relatives is almost always necessary. However, because of the high incidence of colon tumours, evaluation and verification of expanded pedigree data for all colon cancer patients can represent an enormous amount of work. This approach also requires collaboration by the proband and his/her family and knowledge of distant relatives, which may not be available, particularly in countries in which family ties have become attenuated. On the other hand, when large pedigrees are evaluated there is always a risk of false-positive diagnosis based on chance aggregation of tumours or the effects of common environmental risk factors, such as diet (Khoury et al., 1988) .
We have, therefore, developed a stepwise approach for identification of families at risk of HNPCC, which involves an initial assessment of the first-degree pedigree for the presence of six clinical characteristics associated with hereditary cancer syndromes (Ponz de Leon et al., 1993a; Benatti et al., 1993; Percesepe et al., 1994) (Table 1) . When three or more of these characteristics are present. the pedigree is expanded to include second-and third-degree relatives (if possible) and re-evaluated according to the Amsterdam criteria. In a previous study to assess the reliability of this method, only a very small percentage of the first-degree pedigrees with less than three of the elements listed in Table I satisfied the Amsterdam criteria after expansion to secondand third-degrees (Ponz de Leon et al., 1993a) .
The purpose of the present study was to ascertain whether family size does indeed influence the diagnosis of HNPCC according to the Amsterdam criteria. Because of the stepwise approach that we use, expanded pedigrees are available only for those cases in which there is already a suspicion of Lynch syndrome. For this reason, the effect of the first-degree pedigree size was analysed, even though the diagnosis of HNPCC is usually based on the evaluation of extended pedigrees.
Materals and methods

Patients
As previously descnrbed (Percesepe et al., 1994) Table I were subsequently expanded and evaluated according to the Amsterdam criteria: only three (5%) of these extended families were able to satisfy the latter definition (Ponz de Leon et al., 1 993a). In light of these findings, the non-HNPCC diagnoses made on the basis of our initial assessment in 866 probands should not be considered different from those made after expansion in the other 154 non-HNPCC cases. Pedigree expansion is warranted, however, when three or more of our criteria are met by the first-degree family. and all 32 HNPCC probands were classified according to assessment of the Amsterdam criteria in expanded pedigrees. As expected. the results of our analysis indicated that family size plays an important role in determining the outcome of the pedigree assessment: the relative risk of a positive diagnosis increases by 24% with each additional first-degree relative. This association was not dependent on the age of the proband at diagnosis. The latter variable was also significantly associated with the HNPCC diagnosis, the risk of a positive diagnosis increasing by approximateiy 8% with each yearly decrease in the age at diagnosis. The results of our linear discriminant analysis suggest that a negative diagnosis based on evaluation of a first-degree pedigree containing fewer than eight members might well be the result of inadequate data for analysis. In most cases of this type, particularly those in which the number of first-degree relatives is significantly lower than eight. expansion of the pedigree to second-and third-degree relatives is probably advisable to reliably exclude the possibility of HNPCC. In contrast. the possibility of false-positive diagnosis should be considered when it is based on evaluation of more than eight first-degree relatives. Chance aggregation, an effect of common environmental risk factors or other forms of genetic susceptibility might be suspected. for example in positive families of this type with no clear pattern of autosomal dominant transmission, a predominance of left colon tumours or a high mean age of tumour onset. Based on the surveillance. epidemiology and end results (SEER) data. Lynch et al. (1993) have recently estimated that. as a random event, the probability that an affected proband under 50 with 12 relatives will meet the Amsterdam criteria is approximately three times higher than that for a proband of the same age with only six first-degree relatives.
The frequency of Lynch syndrome observed in the population we analysed (3%) is consistent with previous estimates based on phenotypical analysis for other Western countries (Mecklin. 1987; Vasen et al., 1989; Stephenson et al.. 1991) . even though the approaches used in these studies were slightly different from those proposed by the ICG-HNPCC. However, the fact that pedigree size was found to be an independent predictor of the Amsterdam-cnrteria-based diagnosis raises questions on the sensitivity as well as on the specificity of all of these clinical criteria in identifying HNPCC families. In a preliminary study by Leach et al. (1993) Large-scale screening for mutations of the known mismatch repair genes does not seem at present feasible, since the study of mutations is difficult, time consuming and possible only in a few laboratories. On the other hand, the definitive characterisation of selected HNPCC families on a biomolecular basis will allow further insights on fundamental issues, such as the penetrance of gene mutations, their expressivity (the spectrum of organs and tissues involved) and the natural history of the disease.
In conclusion, we feel that clinical screening is still the first-line approach to identification of HNPCC. In this setting the criteria proposed by the ICG-HNPCC can be quite useful, but their limitations must be kept in mind. The ICG itself has recognised some of these shortcomings and has pointed out that their criteria should not be intended as a strict definition of Lynch syndrome. The effect of family size on these diagnoses should be considered in interpreting the outcome of pedigree studies, and other characteristics should be assessed when doubts anrse. As birth rates in Western countries continue to decline, clinical recognition of Lynch syndrome in the general population may become increasingly difficult.
